Cargando…
GPR109A and Vascular Inflammation
GPR109A has generated expanding interest since its discovery as the receptor for niacin a decade ago, along with deorphanisation as the receptor for endogenous ligand 3-hydroxy-butyrate shortly after. This interest is generated especially because of the continuing exploration of niacin’s “pleiotropi...
Autores principales: | Chai, Joshua T., Digby, Janet E., Choudhury, Robin P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Current Science Inc.
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3631117/ https://www.ncbi.nlm.nih.gov/pubmed/23526298 http://dx.doi.org/10.1007/s11883-013-0325-9 |
Ejemplares similares
-
Oxidized PLs and Vascular Inflammation
por: Aldrovandi, Maceler, et al.
Publicado: (2013) -
Modulation of 11β-Hydroxysteroid Dehydrogenase as a Strategy to Reduce Vascular Inflammation
por: Hadoke, Patrick W. F., et al.
Publicado: (2013) -
Molecular Pathways Regulating Macrophage Polarization: Implications for Atherosclerosis
por: Hoeksema, Marten A., et al.
Publicado: (2012) -
Nicotinic Acid Receptor GPR109A Is Down-Regulated in Human Macrophage-Derived Foam Cells
por: Chai, Joshua T., et al.
Publicado: (2013) -
Niacin Ameliorates Neuro-Inflammation in Parkinson’s Disease via GPR109A
por: Giri, Banabihari, et al.
Publicado: (2019)